We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHI
3976
DELISTED
Advanced Health Intelligence Ltd
AHI
$29K ﹤0.01%
+4,750
New +$39.9K
BCDA icon
3977
BioCardia
BCDA
$12.3M
$28K ﹤0.01%
+913
New +$27.1K
QNTM
3978
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$18.5M
$28K ﹤0.01%
502
+297
+145% +$18K
VYNT
3979
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$28K ﹤0.01%
3,882
-15,386
-80% -$89.4K
HUSN
3980
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$28K ﹤0.01%
14,675
+4,312
+42% +$16.1K
AMST icon
3981
Amesite
AMST
$6.48M
$27K ﹤0.01%
3,992
+2,984
+296% +$27.6K
PRFX icon
3982
PRF Technologies Ltd
PRFX
$3.04M
$27K ﹤0.01%
18
+6
+50% +$8.41K
PZG icon
3983
Paramount Gold Nevada
PZG
$96.1M
$27K ﹤0.01%
42,000
-42,200
-50% -$29.4K
PHCF
3984
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$27K ﹤0.01%
5,150
+2,167
+73% +$13.2K
NVIV
3985
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$27K ﹤0.01%
3,172
+1,916
+153% +$18.2K
INUV icon
3986
Inuvo
INUV
$15.1M
$26K ﹤0.01%
5,240
+1,570
+43% +$7.26K
SNGX icon
3987
Soligenix
SNGX
$5.54M
$26K ﹤0.01%
151
+59
+64% +$9.48K
MOTS
3988
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$26K ﹤0.01%
+245
New +$28.6K
GET
3989
DELISTED
Getnet Adquirencia e Servicos para Meios de Pagamento S.A. American Depositary Shares
GET
$26K ﹤0.01%
+16,700
New +$22.2K
PTE
3990
DELISTED
PolarityTE, Inc. Common Stock
PTE
$26K ﹤0.01%
4,280
+972
+29% +$11.2K
DCOY
3991
Decoy Therapeutics
DCOY
$2.19M
$25K ﹤0.01%
2
-3
-60% -$47.3K
BAOS icon
3992
Baosheng Media Group
BAOS
$920K
$24K ﹤0.01%
2,167
-8,018
-79% -$109K
PME
3993
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$24K ﹤0.01%
+37,900
New +$23.8K
PALI icon
3994
Palisade Bio
PALI
$330M
$23K ﹤0.01%
28
-80
-74% -$64.7K
XHG
3995
XChange TEC
XHG
$49M
$23K ﹤0.01%
1
-1
-50% -$32.8K
TLIS
3996
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$23K ﹤0.01%
+1,107
New +$38.3K
SVRA icon
3997
Savara
SVRA
$1.12B
$22K ﹤0.01%
16,700
-327,792
-95% -$395K
BGM
3998
BGM Group Ltd
BGM
$113M
$22K ﹤0.01%
2,610
+50
+2% +$516
HURA
3999
TuHURA Biosciences
HURA
$138M
$22K ﹤0.01%
31
-85
-73% -$61.2K
BIOL
4000
DELISTED
Biolase, Inc.
BIOL
$22K ﹤0.01%
25
+10
+67% +$9.22K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.